BBOT logo
BBOT NASDAQ US

BridgeBio Oncology Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Feb 2024
$8.91
▼ $-0.12 (-1.33%)
Vol 165K
5
Quality Score
fail
Mkt Cap
$1.0B
P/E
212.3
ROE
2.5%
D/E
0.00
Beta
0.18
52W
$9–$15

Wall Street Consensus

15 analysts · Apr 2026
6
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
93.3%
Buy Rating

Price Chart

Similar Stocks

MGTX
MeiraGTx Holdings PLC
$639.9M
SLDB
Solid Biosciences Inc
$439.4M
REPL
Replimune Group Inc
$762.5M
DSGN
Design Therapeutics Inc
$534.3M
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
PURR
Hyperliquid Strategies Inc
ALLO
Allogene Therapeutics Inc
$307.9M

Earnings

Beat rate: 50.0%
Next Report May 07, 2026
EPS Estimate: $-0.54
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.54 — —
Dec 2025 $-0.53 $-0.49 +$0.04
Sep 2025 $-0.40 $-1.03 $-0.63

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 2.5% 2.5% 2.5% 2.5% 2.5% 2.5%
P/E (TTM) — 47.99 213.69 212.09 207.03 212.29
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.33 0.33 0.33 0.33 0.33 0.33

Key Ratios

ROA (TTM)
2.4%
EPS (TTM)
$0.20
52W High
$14.87
52W Low
$8.70
$8.70 52-Week Range $14.87

How does BBOT compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

BBOT AAPG ABEO ABOS ABP

BBOT valuation vs Biotechnology peers

P/E ratio
212.3
▲ 1030% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼ 0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

BBOT profitability vs Biotechnology peers

ROE
2.5%
▲ 104% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
2.4%
▲ 105% above peers (-46.7%)
vs Peers
vs Industry
Top tier

BBOT financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.3
▼ 92% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼ 82% below peers (1.0)
vs Peers
vs Industry
More volatile

BBOT fundamentals radar

BBOT Peer median Industry

BBOT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

BBOT vs peers: key metrics

Latest News

Abbott Earnings Preview: What to Expect
Yahoo Finance · Mar 26
Is Abbott Laboratories (ABT) A Good Stock To Buy Now?
Yahoo Finance · Mar 21
Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India
Yahoo Finance · Mar 17